Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of Anti-melanoma differentiation-associated gene 5 (MDA-5) antibody-positive dermatomyositis with rapidly progressive interstitial lung disease complicated by bilateral breast cancer following the additional tofacitinib: A case report.
Yamane T, Kitayama M. Yamane T, et al. Among authors: kitayama m. Mod Rheumatol Case Rep. 2024 Sep 27:rxae060. doi: 10.1093/mrcr/rxae060. Online ahead of print. Mod Rheumatol Case Rep. 2024. PMID: 39330992
Survival Outcome Superiority of Total Pharyngolaryngectomy Compared with Chemoradiotherapy for T4aM0 Hypopharyngeal Squamous Cell Carcinoma: A Nationwide Database Study of Japan.
Omura G, Eguchi K, Yoshimoto S, Honma Y, Fushimi C, Sakai T, Matsumoto Y, Sakai A, Kitayama M, Kawakita D, Kirita T, Kodaira T, Nakamizo M, Nibu KI. Omura G, et al. Among authors: kitayama m. Ann Surg Oncol. 2024 Nov;31(12):8206-8213. doi: 10.1245/s10434-024-15994-3. Epub 2024 Aug 12. Ann Surg Oncol. 2024. PMID: 39133449
18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma.
Tanaka H, Hashiguchi K, Tabuchi M, Nessipkhan A, Akashi T, Shiota J, Kitayama M, Matsushima K, Yamaguchi N, Arai J, Kanetaka K, Nakashima M, Kudo T, Nakao K, Akazawa Y. Tanaka H, et al. Among authors: kitayama m. Sci Rep. 2024 Jul 30;14(1):17493. doi: 10.1038/s41598-024-65066-5. Sci Rep. 2024. PMID: 39080310 Free PMC article.
Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan.
Ichisaka T, Sano D, Kijima N, Kawakita D, Yoshimoto S, Kitayama M, Nibu KI, Oridate N. Ichisaka T, et al. Among authors: kitayama m. Oral Oncol. 2024 Oct;157:106942. doi: 10.1016/j.oraloncology.2024.106942. Epub 2024 Jul 18. Oral Oncol. 2024. PMID: 39029387
Correction: Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kikuchi M, et al. Alzheimers Res Ther. 2024 Jul 10;16(1):158. doi: 10.1186/s13195-024-01514-8. Alzheimers Res Ther. 2024. PMID: 38987831 Free PMC article. No abstract available.
Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kikuchi M, et al. Alzheimers Res Ther. 2024 Feb 27;16(1):45. doi: 10.1186/s13195-024-01414-x. Alzheimers Res Ther. 2024. PMID: 38414085 Free PMC article.
220 results